tiprankstipranks
ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
US Market
IMUC
ImmunoCellular Therapeutics
RESEARCH TOOLSreports
Want to see IMUC full AI Analyst Report?

ImmunoCellular Therapeutics (IMUC) Income Statement

186 Followers

ImmunoCellular Therapeutics Income Statement

Last quarter (Q4 2022), ImmunoCellular Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, ImmunoCellular Therapeutics's net income was $-464.52K. See ImmunoCellular Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 1.83M$ 2.01M$ 1.82M$ 2.89M$ 2.61M
Depreciation and Amortization
$ 0.00$ 0.00$ 167.90K$ 228.49K$ 2.61M
EBITDA
$ -1.83M$ -929.09K$ -999.29K$ -2.21M$ -1.00
Operating Income
$ -1.83M$ -2.01M$ -1.65M$ -2.89M$ -2.61M
Other Income/Expenses
$ -95.01K$ 114.22K$ -63.70K$ 238.41K$ -65.71K
Pretax Income
$ -1.92M$ -1.89M$ -1.72M$ -2.65M$ -2.68M
Net Income
$ -1.92M$ -1.89M$ -1.61M$ -2.65M$ -2.68M
Per Share Metrics
Basic EPS
$ -0.02$ -0.02$ -0.01$ -0.02$ -0.06
Diluted EPS
$ -0.02$ -0.02$ -0.01$ -0.02$ -0.06
Weighted Average Shares Outstanding
 126.50M 115.10M 113.27M 113.27M 45.43M
Weighted Average Shares Outstanding (Diluted)
 126.50M 115.10M 113.27M 113.27M 45.43M
Currency in USD

ImmunoCellular Therapeutics Earnings and Revenue History